TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By George Magrath, M.D.
Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference

Opus Genetics, a clinical-stage biopharmaceutical company, will present at the J.P. Morgan 2026 Healthcare Conference. The company focuses on developing gene therapies for inherited retinal diseases, with seven AAV-based programs targeting various genetic mutations.

Insights
GOOG   positive

Currently above $3 trillion market cap


IRD   positive

The company is actively developing innovative gene therapies, has a robust pipeline of treatment programs, and is presenting at a major healthcare conference, indicating growth and potential